Chapter 3 Special topics (Fitz)

  1. AST and ALT range
    0-40unit/L
  2. AST/ALT measures what and reflects how?
    • hepatocellular damage
    • ↑ in valproate therapy, hepatitis, and cirrhosis
    • ↓ in chronic ETOH liver disease
  3. Alkaline phosphate (ALP) range
    30-120units/L
  4. Alk phos (ALT) measures what and reflects how?
    • cholestasis, bile flow
    • hepatocellular damage
    • ↑ in gallbladder and liver dz as well as bone injury/growth
    • ex: young boy will by high
  5. Creatine kinase (CK) range
    0-139
  6. Creatine kinase (CK) measures and reflects what?
    • muscle injury
    • increased in MI, neuromalignant syndrome
  7. BUN range and measures what
    • 8-18 for kidney function
    • increased in lithium therapy
  8. Creatinine range and measures what?
    0.6-1.2 for kidney function increased with lithium therapy
  9. GFR range and is best for what
    • >90 and overall kidney function 
    • note: geriatric will have normal Cr but reduced GFR d/t muscle mass
    • -no dose adjustments when GFR>60
  10. Valproate and anti-epiletpic labs for initiation and how often?
    • liver panel (ALT, ALT, AST), bili, albumin, CBC
    • baseline, monthly then every 6-24 monhs
  11. Valproate range?
    50-120
  12. Valproate, when to stop med?
    if ALT/AST >2-3x upper limit
  13. Valproate common complications/SE?
    • N/V/jaundice
    • thrombocytopenia and neutropenia
    • easily bruising, etc
    • SJS (rare)
    • screening for HLA-B, high in Asian
  14. Lithium range acute tx then maintenance
    • 0.8-1.2
    • 0.6-1.0
  15. Lithium initial lab work and test 
    as well as maintenance
    • BUN/Cr, GFR, TSH, electrolytes, CBC, hCG, and UA
    • baseline EKG (50+ ekg q6-12mo)
  16. When do you check lithium levels when initiating?
    • 12 hours post dose initiation (trough) 
    • 4 days --> then every 4 days
  17. How is lithium absorbed and metabolized
    • via GI tract and is NOT metabolized 
    • excreted 100% unchanged in urine
  18. When is lithium contraindicated (3 pts)?
    Pts in ACUTE renal failure, dehydration, and NA depletion
  19. Lithium is OK for stable KD and transplants, but when do you make changes
    reduce if GFR<60
  20. Lithium affects by renal function (3):
    • -Dehydration= increase levels
    • -increased Na= decrease in levels 
    • -decreased Na= increase levels
  21. What level can you see lithium toxicity at?
    1.5 but typically occur >2
  22. Lithium toxicity sxs
    lethargy, fatigue, clumsiness, muscle cramping, N/V, tremors, confusion, blurred vision, nystagmus, AMS, arrhythmias,
  23. Education for lithium pts
    sxs of toxicity, lab work, and avoid dehydration
  24. Which meds can increase lithium levels
    • -ACE, ARBs, NSAIDs
    • -K sparring diuretics
    • -Thiazide diuretics
    • -Tetracyclines, Metronidazole
  25. Which med can decrease lithium levels?
    Theophylline
  26. Possible effects of being on lithium
    • -thyroid hypofunction, goiter
    • -cardiac events
    • -Renal, PPP
    • -fine hand tremor
    • -weight gain
  27. Clozapine initiation lab work
    WBC--> absolute neutrophil count (ANC)

    worry about WBC so low they can't fight infection
  28. What level does ANC have to be to start Clozapine and when do we stop it?
    • ANC>1500 
    • stop if <1000
  29. Clozapine maintenance lab work
    • ANC weekly for 6 months 
    • then q2 weeks for 6 months 
    • monthly if ANC 1500
  30. Highest risk of what with Clozapine
    agranulocytosis
  31. What is a substrate?
    uses enzyme to modify so it can reach drug site of action
  32. Which meds use 2D6 substrate pathways?
    • -Fluoxetine, Paroxetine, Sertraline 
    • -Venlafaxine, Duloextine 
    • -TCAs
    • -Haloperidol, Aripiprazole 
    • -BBs
  33. Which meds use the 1A2 substrate pathways?
    • Duloxetine, mirtazapine, clozapine, 
    • haloperidol, olanzapine, asenapine
  34. Which meds use 3A4 substrate pathways? What % are meds
    • Sildenafil, statins, xanax, venlafaxine 
    • 50%
  35. What is an inhibitor?
    blocks pathways and keeps substrate form exiting--> can cause toxicity
  36. Which meds use the 2D6 inhibitor pathways?
    • Fluoxetine, paroxetine, bupropion, 
    • duloxetine
  37. Which meds use the 1A2 inhibitor pathways?
    Fluvoamine, fluoxetine, paroxetine, Sertraline
  38. What is an inducer
    accelerates, and reduces substrate level
  39. Cranial nerves
  40. Hypothyroidism mnemonic
    • Mom's so tired
    • -mem loss
    • -obesity
    • -menorrhagia 
    • -slowness
    • -skin and hair dryness
    • -onset graudual
    • -tiredness
    • -intolerance to cold
    • -raised BP
    • -energy levels fall
    • -depression/delayed reflexes
  41. Hyperthyroidism mnemonic
    • SWEATING
    • -sweating
    • -weight loss
    • -emotional lability
    • -appetite increased
    • -tremor/tachy
    • -intolerance of heat, irreg men, irritability 
    • -nervousness 
    • -goiter, GI problems 
    • -
  42. What are the most common thyroid test
    • TSH:most reliable and r/o
    • TF4 (free T4): f/u test to support dx
    • TPO: helps detect autoimmune thy dz
  43. What are the normal ranges for TSH and Free T4?
    • TSH 0.4-4.0
    • Free T4 10-27
  44. What does high TSH and low FT4 indicate?
    untreated hypothyroidism or inadequate thyroxine dose
  45. What does a low TSH and FT4 indicate?
    untreated hyperthyroidism or high thyroxine dose
  46. When should DM testing start if no risk factors
    45 yo q 3 years
Author
maria_mm_10
ID
358958
Card Set
Chapter 3 Special topics (Fitz)
Description
Chapter 3 Special topics (Fitz)
Updated